In Brief This Week: Veracyte; Danaher; Insight Genetics; Quest Diagnostics; RayBiotech; Biomatrica, Cambio; Seahorse Bioscience | GenomeWeb

NEW YORK (GenomeWeb News) – In June, Veracyte entered into a loan and security agreement with an unnamed financial institution for term loans of up to $10.0 million in aggregate, the company said in its recent Form 10-Q filed with the US Securities and Exchange Commission. In June, Veracyte, which went public in November, drew down $5 million in funds under the agreement. It is required to repay the outstanding principal in 30 equal installments starting 18 months after the date of the borrowing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.